| Tag | Content |
|---|
EnhancerAtlas ID | HS098-33446 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr2:230272060-230274110 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr2:230273435-230273453 | GGAGGAAAGGAAGTAAGA | + | 6.08 | | EWSR1-FLI1 | MA0149.1 | chr2:230273431-230273449 | GGAAGGAGGAAAGGAAGT | + | 7.2 | | FOSL2 | MA0478.1 | chr2:230272083-230272094 | GGATGACTCAT | + | 6.62 | | JUN(var.2) | MA0489.1 | chr2:230273349-230273363 | ATGACTCATCCTTT | - | 6.64 | | JUNB | MA0490.1 | chr2:230272083-230272094 | GGATGACTCAT | + | 6.62 | | ZNF263 | MA0528.1 | chr2:230273432-230273453 | GAAGGAGGAAAGGAAGTAAGA | + | 6.78 | | ZNF263 | MA0528.1 | chr2:230273137-230273158 | TCCTCCCTCTCTCCCTTCCCC | - | 7.07 | | ZNF263 | MA0528.1 | chr2:230273116-230273137 | TCTCTCTCCTCCTCCTGCCCC | - | 7.29 | | ZNF263 | MA0528.1 | chr2:230273110-230273131 | TCTCTCTCTCTCTCCTCCTCC | - | 8.22 | | ZNF263 | MA0528.1 | chr2:230273125-230273146 | TCCTCCTGCCCCTCCTCCCTC | - | 8.29 | | ZNF263 | MA0528.1 | chr2:230273122-230273143 | TCCTCCTCCTGCCCCTCCTCC | - | 9.3 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09823 | chr2:230270641-230276217 | CD14 | | SE_56283 | chr2:230270544-230276150 | u87 | | SE_64867 | chr2:230270705-230274741 | NHEK |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 230273013 | 230273684 | | chr2 | 230273717 | 230274042 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I229406 | chr2 | 230270762 | 230275830 |
|
Enhancer Sequence | CCTGCAGAGA AACAAGCAAA ACAGGATGAC TCATCCAGGA CTCTCTGGCT CCCATGGCCT 60
CTGAAAGCAA AGTCGGAACT CTCTGGAACA ATGCGAGGGA GATTCCCAGC GTGGGTGTGT 120
GTGGGTGAGT GTATACACAC GTGCCCACTC ATGATTTTAG ATTGTTGTAA AAACTTGCCT 180
TATGAGAAAG TAACACATTC GATCACTGTC CATAGGTCCC ACCATAGTCT TTTATCTGTA 240
CTTTCTCTGC CTACGTGTCC CAAAGCCTGG GGAACAGAAA GTTAAAAGCC TGAAAGATAA 300
ATTAATCAAT AGCAAATGCT TTATAAGTCT CCAAAAGAAA CAGAAAATAT CTAGATGGCC 360
TTGAGAAAAT ATAATATTAG CAACCTGAAA GTGAAGATTT GGAATCAGAT ATTTAAGTGA 420
GTCCCAGTTC TACTTTGAAG AACTGCAGGG GAGAGGGGAA GCCGTGTGAT ACTTAGACTT 480
CATTCTCAAA GACATCACTG CATGCTTTAT GTCTAATTTA TTCCTCACAA CAACACTATG 540
AGACAATTAT CCTTATTCCT CCATTTTACA GATGAGGAAA CTGAGGAAAG AGTCGAAGAT 600
CACAAGCCTG GTAAGAAAGG AGCTGGGATT TGAAGCTGCC CGTAATCCCA TCCCAGAGTC 660
TGTGTTTGCT AAGTAGGCTG TTGAGAGTGA CCCTGAATTG ACTGTGGAAA TATACAAAAC 720
TCTATGGAGC TCAGCACTCG TTTAACAAAG AAGAGGCATT TTTTAAAAAA TCTGTAAAGT 780
AAAACAGACA GCTTCTCATT TACTTTTTTT AAAAAAAAAA GACTGTGTGT GCATGTATGT 840
ACGCAAATGC CTGAAGTGGG ACTGGATTAC TTCCAGGAGA CTTGATTACT TTGATTTTCA 900
CATCTGTGTA TTTCTACATT ACTGGCACCT TTTTTACAAG TATCTATTTT TTTATAATTT 960
TATTAAAAAC TTTAAAAATC TAATGCTATT TGAAAGGTGG GATATCTGCT GATGTTACAC 1020
TGGATGCCAA GATGGATGAA TAGATTAGTG TCTCTCTCTC TCTCCTCCTC CTGCCCCTCC 1080
TCCCTCTCTC CCTTCCCCTA TCCCCACCCT TTGGAGAGAA AGATAAATTA CATTCTACCT 1140
TGCCTAAGAA CGTACATAAT GATATGCCCA CACTTCCCAA CAGCCTCAAG AAAAATATGC 1200
ATAAAGCAAA TAGTAACTGA ATGGTATTTA CTTAATTTTC TCTGCACTTC ATTACTTAGC 1260
TCATGTTGTG CAAGGGACTG CCACACCCAA TGACTCATCC TTTAGGCACT GAAATCATCC 1320
TTGCTGGGCT TTTCCCTTAT TTATTTCTCA ATGCCTTAAG AATAGGGCTC AGGAAGGAGG 1380
AAAGGAAGTA AGAGAAAATA GAAATGGAAC TTCCTATCTA TATTCACACT AATGACTTAT 1440
TTGAGCCAGG TAAAGCTCAA ATTTTAGAAT AAATGACCTG TAATTCTTTT TCATCCTTTG 1500
CCCCTCCTAG CCAAGCCATC AACAATATTC TGTCAGGTAT TTTTCTGAAG TGTCTTTCAG 1560
ATCTTTGCCT TTCTTTCCTT CCTGAGACCA CCCCTGTGAT CCCACTGCCT CGTGCCTGGT 1620
GGGATACAGC ATCCCGCAGC CATGTCTTAG TTTCCTCTGT CTCCAGGGAC TTGAACGAGC 1680
CTCCTCAACT TCCTTCATCC CTAACCCAGG TTGCATGGTA ACATAAAAGA TCAAAATAAT 1740
GTTAAGATTA GCATAAATCT GGTCATTCTT CTTCATTTGG GTGTGTACAG CCTCTTCTCC 1800
CAGGAGTCTC TTATTTTTAC TTTCCTACTG ATACACAAGT AGCCTGGGCT CAATTGAAAG 1860
AATAAAAAGC AGAAGAGTCT TTTCTGCTTT AAAATGTTTA TTGCAACACA AAGACTCACA 1920
TATTTACAAG TTCCCACTGG GCTGATCAAT GGGAGCCAAG TGACAAAAAA GACTTTTGGT 1980
TGTAGTGGGA AATACGGCCA CCACCAAAGT TCAGAGGTGC CTGAAGCCTA GAAAACATTT 2040
CCATTAGACC 2050
|
